Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457)

Head and Neck

Volumn 32, Issue 9, 2010, Pages 1161-1166

  Lee, Ji In ^a   Kim, Ji Young ^a   Choi, Joon Young ^a   Kim, Hee Kyung ^a   Jang, Hye Won ^a   Hur, Kyu Yeon ^a   Kim, Jae Hyeon ^a   Kim, Kwang Won ^a   Chung, Jae Hoon ^a   Kim, Sun Wook ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Certified Reference Material 457 (CRM 457); differentiated thyroid cancer; immunoradiometric assay; thyroglobulin

Indexed keywords

DIAGNOSTIC AGENT; HUMAN THYROGLOBULIN REFERENCE MATERIAL 457; THYROGLOBULIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HOSPITAL CARE; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; STANDARDIZATION; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

CARCINOMA, PAPILLARY; HUMANS; IMMUNORADIOMETRIC ASSAY; MONITORING, PHYSIOLOGIC; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 78349276941     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21308     Document Type: Article

References (16)

1. Van Herle AJ, Vassart G, Dumont JE,. Control of thyroglobulin synthesis and secretion (second of two parts). N Engl J Med 1979; 301: 307-314.
2. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 1433-1441.
3. Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007; 92: 2487-2495.
4. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-142.
5. Spencer CA,. Thyroglobulin (Tg) measurement. Thyroid 2003; 13: 57-67.
6. Spencer CA,. Thyroid testing for the new millenium. Thyroid 2003; 13: 33-44.
7. Feldt-Rasmussen U, Profilis C, Colinet E, et al. Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivity. Ann Biol Clin (Paris) 1996; 54: 337-342.
8. Feldt-Rasmussen U, Profilis C, Colinet E, et al. Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification. Ann Biol Clin (Paris) 1996; 54: 343-348.
9. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS,. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90: 5566-5575.
10. Davies L, Welch HG,. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
11. Muller R, Buttner P,. A critical discussion of intraclass correlation coefficients. Stat Med 1994; 13: 2465-2476.
12. Chung JK, Park YJ, Kim TY, et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 2002; 57: 215-221.
13. Ahn BC, Bae JH, Jeong SY, et al. Influence of anti-thyroglobulin antibody on the measurement of thyroglobulin using the immunoradiometric assay. J Korean Soc Endocrinol 2004; 19: 42-47.
14. Ahn BC, Seo JH, Bae JH, et al. Effects of anti-thyroglobulin antibody on the measurement of thyroglobulin: differences between immunoradiometric assay kits available. J Korean Soc Nucl Med 2005; 39: 252-256.
15. Whitley RJ, Ain KB,. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med 2004; 24: 29-47.
16. Kohno Y, Tarutani O, Sakata S, Nakajima H,. Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarcinoma. J Clin Endocrinol Metab 1985; 61: 343-350.